Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Total 13F shares
-
18,449,209
-
Share change
-
-135,165
-
Total reported value
-
$2,777,995,739
-
Put/Call ratio
-
35%
-
Price per share
-
$150.61
-
Number of holders
-
219
-
Value change
-
-$14,039,954
-
Number of buys
-
110
-
Number of sells
-
101
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2015
As of 30 Jun 2015,
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by
219 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,449,209 shares.
The largest 10 holders included
ATLANTA CAPITAL MANAGEMENT CO L L C, VANGUARD GROUP INC, ARIEL INVESTMENTS, LLC, BlackRock Fund Advisors, LEVIN CAPITAL STRATEGIES, L.P., BlackRock Institutional Trust Company, N.A., WELLS FARGO & COMPANY/MN, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, ACADIAN ASSET MANAGEMENT LLC, and STATE STREET CORP.
This page lists
218
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.